Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2007
Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptorKrisztina Kohalmy, Viola Tamási, László Kóbori, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2010
Inhibition of human sterol Δ7-reductase and other postlanosterol enzymes by LK-980, a novel inhibitor of cholesterol synthesisJure Acimovic, Tina Korosec, Matej Seliskar, et al.
British Journal of Clinical Pharmacology|September 28, 2020
Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A-status in liver transplant recipientsNóra Csikány, Ádám Kiss, Máté Déri, et al.
Circulation Research|April 30, 2013
ABCC6 is a basolateral plasma membrane proteinViola Pomozi, Olivier Le Saux, Christopher Brampton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2008
Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agentKatalin Monostory, Jean-Marc Pascussi, Pál Szabó, et al.
Scientific Reports|July 18, 2024
PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell modelsDávid Gamba, Nicholas van Eijk, Katalin Lányi, et al.
Expert Opinion on Drug Safety|February 22, 2023
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisoloneTamás Resál, Katalin Mangó, Péter Bacsur, et al.
ESC Heart Failure|February 26, 2021
Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus-positive patient with fulminant myocarditisZsofia Szakal-Toth, Janos Szlavik, Adam Soltesz, et al.
Bioorganic & Medicinal Chemistry|February 24, 2018
Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitorsBence Szilágyi, Péter Kovács, György G Ferenczy, et al.
European Journal of Hospital Pharmacy : Science and Practice|July 8, 2025
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactionsDénes Kleiner, Faraz Haghverdi, Orsolya Szépe, et al.
Pageof 8